Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levamizole to reduce mortality in patients with >50% total body surface area burns
IRCT138903044020N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levamisole in burn injury, sponsored by Iran University of Medical Sciences. Started Jul 2010; status: completed.
02
Drugs
levamisole
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT138903044020N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138903044020N1.